Chiral Quest
Suzhou, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Chinese CDMO specializing in asymmetric hydrogenation technology for pharmaceutical intermediates and custom synthesis services.
OncologyImmunology
Technology Platform
World-class asymmetric hydrogenation technology platform complemented by biocatalysis and flow chemistry capabilities for pharmaceutical intermediate synthesis and process development.
Opportunities
Growing demand for specialized chiral chemistry services in pharmaceutical manufacturing and increasing outsourcing of intermediate production to China-based CDMOs.
Risk Factors
Intense competition in the CDMO sector, regulatory challenges in serving international markets, and potential intellectual property concerns from clients.
Competitive Landscape
Competes with other specialized CDMOs in asymmetric synthesis such as Codexis and broader Chinese CDMOs like WuXi AppTec; differentiates through focused asymmetric hydrogenation expertise and integrated technology platforms.